LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$9.29
-4.82%
Mkt Cap $294.10M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (5 analysts)
$61.50
Range $56.00 – $67.00
Implied Upside
+562.0%
Consensus $61.50 vs current $9.29
NASDAQ·Healthcare·Biotechnology
$9.29
-4.82%
Mkt Cap $294.10M
Buy
3
Hold
0
Sell
0
Price Target (5 analysts)
$61.50
Range $56.00 – $67.00
+562.0%
Consensus $61.50 vs current $9.29